Cargando…
Impacts of additional cycles of neoadjuvant immunotherapy on surgery in non‐small‐cell lung cancer
OBJECTIVE: Whether cycle number influences the subsequent pathological or surgical outcomes remained unclear. This study aimed to assess the efficacy and surgical safety of neoadjuvant immunochemotherapy‐based treatment in the real‐world setting. METHODS: Clinical data of patients who received neoad...
Autores principales: | Chen, Jiawei, Ang, Keng‐Leong, Wang, Zhufeng, Lei, Fan, He, Jiaxi, Li, Shuben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175030/ https://www.ncbi.nlm.nih.gov/pubmed/37021595 http://dx.doi.org/10.1111/1759-7714.14867 |
Ejemplares similares
-
Impact of the interval between neoadjuvant immunochemotherapy and surgery on surgical–pathological outcomes in non-small cell lung cancer
por: Chen, Jiawei, et al.
Publicado: (2022) -
Electromagnetic Navigation Bronchoscopy Integrated Non-intubated Uniportal VATS in Localization and Resection of Pulmonary Nodules
por: Wang, Rui, et al.
Publicado: (2022) -
Treatments for combined small cell lung cancer patients
por: He, Jiaxi, et al.
Publicado: (2020) -
Expert consensus on neoadjuvant immunotherapy for non-small cell lung cancer
por: Liang, Wenhua, et al.
Publicado: (2020) -
Effectiveness and safety of bevacizumab in extensive-disease small cell lung cancer: a systemic review and meta-analysis
por: He, Jiaxi, et al.
Publicado: (2021)